Curaleaf Holdings, Inc.
TSXCURA headed into its Q1 2026 earnings with short sellers already retreating — and the results gave them little reason to return. The company posted Q1 EPS of $0.09, against a consensus estimate of $(0.06) — a $0.15 beat. Revenue came in at $324.2M, ahead of the $316.0M forecast. The stock closed 6.3% higher on Tuesday, adding to gains of 4.4% on the week and a remarkable 41% rally…
Snapshot as of 6 May 2026
CURA headed into its Q1 2026 earnings with short sellers already retreating — and the results gave them little reason to return. The company posted Q1 EPS of $0.09, against a consensus estimate of $(0.06) — a $0.15…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CURA — free to start on ORTEX.
Sign up for free →Open CURA on ORTEX